Premium Industrial News

China's Pharmaceutical Companies Could See Wave of Project Completions in 2022

China's Pharmaceutical Companies Could See Wave of Project Completions in 2022

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 145 Words

BEIJING--December 30, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Many Chinese pharmaceutical projects tracked by Industrial Info over the past two years have faced delays due to the COVID-19 pandemic. Many of these projects will be completed before the end of 2022, and 793 projects totaling more than $42 billion in value are expected to kick off in 2022.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?